Marker Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $6,591,075,660 | $1,926 | $1,169 | $1,244 |
Gross Profit | 6,591,073,085 | 1,926 | 1,169 | -1,330 |
EBITDA | -10,681,355,106 | -2,399 | -2,308 | -2,549 |
EBIT | -10,681,352,557 | -5,098 | ||
Net Income | -10,731,308,106 | -2,308 | -2,192 | -2,392 |
Net Change In Cash | 6,591,075,660 | 1,926 | 1,169 | 1,244 |
Free Cash Flow | -10,910,317,792 | 1,197 | -3,567 | -3,837 |
Cash | 19,192 | 8,999 | 7,800 | 11,323 |
Basic Shares | 8,980 | 8,923 | 8,918 | 8,901 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $6,591,080,000 | $3,311 | $9,004 | $1,241 |
Gross Profit | 6,591,080,000 | -7,105 | 5,324 | -1,920 |
EBITDA | -11,118,372,000 | -11,792 | -19,791 | -36,315 |
EBIT | -4,527 | -14,581 | -23,471 | -39,477 |
Net Income | -10,731 | -14,045 | -29,915 | -41,873 |
Net Change In Cash | 6,591,080,000 | 3,311 | 9,004 | 1,241 |
Free Cash Flow | -10,910,324,000 | -16,439 | -31,917 | -30,410 |
Cash | 19,192 | 15,111 | 11,782 | 42,351 |
Basic Shares | 8,980 | 8,809 | 8,351 | 7,650 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$0.42 |
2024-12-31 | -$0.42 |
2024-09-30 | -$0.26 |
2024-06-30 | -$0.29 |
